January 2011
1 post
9 tags
India rejects patent for AIDS drug...
On 30 December 2010, the Indian Patent Office decided that the AIDS combination medicine lopinavir/ritonavir does not merit a patent. The decision marks a major victory for public health, and keeps the door open for generic production of the drug, that health providers such as Médecins Sans Frontières (MSF) rely on to treat patients across the developing world.
Lopinavir/ritonavir (LPV/r) is a...